Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort
Abstract Background Lung epithelial damage, activation of the wound healing cascade, and remodeling of the extracellular matrix (ECM) play a major role in chronic obstructive pulmonary disease (COPD). The pro-peptide of type VI collagen has been identified as the hormone endotrophin. Endotrophin has...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-020-01461-6 |
id |
doaj-e432bd97f6824e32b4de4a568577bf44 |
---|---|
record_format |
Article |
spelling |
doaj-e432bd97f6824e32b4de4a568577bf442020-11-25T03:24:23ZengBMCRespiratory Research1465-993X2020-07-012111610.1186/s12931-020-01461-6Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohortSarah R. Rønnow0Lasse L. Langholm1Morten A. Karsdal2Tina Manon-Jensen3Ruth Tal-Singer4Bruce E. Miller5Jørgen Vestbo6Diana J. Leeming7Jannie M. B. Sand8Nordic Bioscience A/SNordic Bioscience A/SNordic Bioscience A/SNordic Bioscience A/SCOPD FoundationR&D Respiratory Therapy Area Unit, GlaxoSmithKlineDivision of Infection, Immunity and Respiratory Medicine, University of ManchesterNordic Bioscience A/SNordic Bioscience A/SAbstract Background Lung epithelial damage, activation of the wound healing cascade, and remodeling of the extracellular matrix (ECM) play a major role in chronic obstructive pulmonary disease (COPD). The pro-peptide of type VI collagen has been identified as the hormone endotrophin. Endotrophin has been shown to promote fibrosis and inflammation, whereas von Willebrand factor (VWF) is a crucial part of wound healing initiation. Here, we assessed the released and activated form of VWF and endotrophin, the pro-peptide of type VI collagen, serologically to investigate their association with mortality in COPD subjects alone or in combination. Methods One thousand COPD patients with 3 years of clinical follow-up from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort were included. Serum and heparin plasma were collected at 6 months and 1 year, respectively. Competitive ELISA utilizing specific monoclonal antibodies assessed endotrophin/type VI collagen formation (PRO-C6), VWF release (VWF-N), and activated VWF (VWF-A). Biomarker levels were dichotomized into high and low as defined by receiver operating characteristic (ROC) curves based on mortality data. Kaplan-Meier analysis was used to determine hazard ratios for all-cause mortality for biomarkers alone or in combination. Results High levels of PRO-C6, VWF-A, and VWF-N have previously been shown to be individually associated with a higher risk of mortality with hazard ratios of 5.6 (95% CI 2.4–13.1), 3.7 (1.8–7.6), and 4.6 (2.2–9.6), respectively. The hazard ratios increased when combining the biomarkers: PRO-C6*VWFA 8.8 (2.8–27.7) and PRO-C6*VWFN 13.3 (5.6–32.0). Notably, PRO-C6*VWF-N increased more than 2-fold. Conclusion We demonstrated that by combining two pathological relevant aspects of COPD, tissue remodeling, and wound healing, the predictive value of biomarkers for mortality increased notably.http://link.springer.com/article/10.1186/s12931-020-01461-6COPDBiomarkersExtracellular matrix |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sarah R. Rønnow Lasse L. Langholm Morten A. Karsdal Tina Manon-Jensen Ruth Tal-Singer Bruce E. Miller Jørgen Vestbo Diana J. Leeming Jannie M. B. Sand |
spellingShingle |
Sarah R. Rønnow Lasse L. Langholm Morten A. Karsdal Tina Manon-Jensen Ruth Tal-Singer Bruce E. Miller Jørgen Vestbo Diana J. Leeming Jannie M. B. Sand Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort Respiratory Research COPD Biomarkers Extracellular matrix |
author_facet |
Sarah R. Rønnow Lasse L. Langholm Morten A. Karsdal Tina Manon-Jensen Ruth Tal-Singer Bruce E. Miller Jørgen Vestbo Diana J. Leeming Jannie M. B. Sand |
author_sort |
Sarah R. Rønnow |
title |
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort |
title_short |
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort |
title_full |
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort |
title_fullStr |
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort |
title_full_unstemmed |
Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort |
title_sort |
endotrophin, an extracellular hormone, in combination with neoepitope markers of von willebrand factor improves prediction of mortality in the eclipse copd cohort |
publisher |
BMC |
series |
Respiratory Research |
issn |
1465-993X |
publishDate |
2020-07-01 |
description |
Abstract Background Lung epithelial damage, activation of the wound healing cascade, and remodeling of the extracellular matrix (ECM) play a major role in chronic obstructive pulmonary disease (COPD). The pro-peptide of type VI collagen has been identified as the hormone endotrophin. Endotrophin has been shown to promote fibrosis and inflammation, whereas von Willebrand factor (VWF) is a crucial part of wound healing initiation. Here, we assessed the released and activated form of VWF and endotrophin, the pro-peptide of type VI collagen, serologically to investigate their association with mortality in COPD subjects alone or in combination. Methods One thousand COPD patients with 3 years of clinical follow-up from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) cohort were included. Serum and heparin plasma were collected at 6 months and 1 year, respectively. Competitive ELISA utilizing specific monoclonal antibodies assessed endotrophin/type VI collagen formation (PRO-C6), VWF release (VWF-N), and activated VWF (VWF-A). Biomarker levels were dichotomized into high and low as defined by receiver operating characteristic (ROC) curves based on mortality data. Kaplan-Meier analysis was used to determine hazard ratios for all-cause mortality for biomarkers alone or in combination. Results High levels of PRO-C6, VWF-A, and VWF-N have previously been shown to be individually associated with a higher risk of mortality with hazard ratios of 5.6 (95% CI 2.4–13.1), 3.7 (1.8–7.6), and 4.6 (2.2–9.6), respectively. The hazard ratios increased when combining the biomarkers: PRO-C6*VWFA 8.8 (2.8–27.7) and PRO-C6*VWFN 13.3 (5.6–32.0). Notably, PRO-C6*VWF-N increased more than 2-fold. Conclusion We demonstrated that by combining two pathological relevant aspects of COPD, tissue remodeling, and wound healing, the predictive value of biomarkers for mortality increased notably. |
topic |
COPD Biomarkers Extracellular matrix |
url |
http://link.springer.com/article/10.1186/s12931-020-01461-6 |
work_keys_str_mv |
AT sarahrrønnow endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT lassellangholm endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT mortenakarsdal endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT tinamanonjensen endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT ruthtalsinger endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT bruceemiller endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT jørgenvestbo endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT dianajleeming endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort AT janniembsand endotrophinanextracellularhormoneincombinationwithneoepitopemarkersofvonwillebrandfactorimprovespredictionofmortalityintheeclipsecopdcohort |
_version_ |
1724601833474752512 |